Missense mutations in NLGN2 or NLGN3 have been associated with several neuropsychiatric diseases, such as schizophrenia (Sun et al., 2011) and autism (Jamain et al., 2003; Xu et al., 2014; Parente et al., 2017). Here, NLGN2 is linked to schizophrenia.